Updated safety of lenvatinib + pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer: Study 309/KEYNOTE-775 Meeting Abstract
| Authors: | Makker, V.; Colombo, N.; Casado Herráez, A.; Monk, B.; Mackay, H.; Santin, A.; Miller, D.; Moore, R.; Ray-Coquard, I.; Shapira-Frommer, R.; Ushijima, K.; Yonemori, K.; Kim, Y. M.; Alia, E. G.; Sanli, U.; Xie, R.; Zale, M.; McKenzie, J.; Barresi, G.; Lorusso, D. |
| Abstract Title: | Updated safety of lenvatinib + pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer: Study 309/KEYNOTE-775 |
| Meeting Title: | IGCS 2022 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Sep 29-Oct 1 |
| Meeting Location: | New York, NY |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2022-12-01 |
| Start Page: | A11 |
| Language: | English |
| ACCESSION: | WOS:000899252300019 |
| DOI: | 10.1136/ijgc-2022-igcs.20 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O018/#482 -- Source: Wos |
